Integrative Diagnosis for SCD and Other RADs
Recruiting
Observational Study
Sickle Cell Disease
Thalassaemia
Congenital Dyserythropoietic Anemia (CDA)
Enzyme Disorder; Anemia
Spherocytosis, Hereditary
Stomatocytosis
Hemoglobin Disorder
Anemia Due to Membrane Defect
Rare Anemia Disorders
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
INTEGRA aims at enabling personalized medicine for RHADs patients by the establishment of an integrative diagnostic approach based on deep phenotypic and genetic characterization through combining new generation methodologies.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients sustaining a confirmed or suspected diagnosis of an hereditary rare hemolytic anemia:
* Sickle cell disease
* Thalassemic syndromes
* Congenital dyserythropoietic anemia
* Enzymopathy
* Unstable Hemoblogin / Altered oxygen affinity
* Hereditary stomatocytosis
* Heredi…
Contacts